Integrating the biological knowledge needed to identify cancer "driver" mutations remains a challenge due to: 1) Heterogeneous experimental data 2) Distributed biomedical data sources 3) Controlled access clinical information
Objective
Our approach to help identify therapeutic targets for cancer required the interoperation between three components:
b) The TCGA (The Cancer Genome Atlas) data model was identified by domain experts using S3DB.
a) The S3DB object model was used as a knowledge organization system for experimental results.
c) The Linked Open Drug Data (LODD) Cloud was used to link TCGA experimental results and biological assertions.
Results
Linking experimental results with biological knowledge in the LODD cloud enabled biology domain experts to easily identify relevant cancer "driver" mutations. 
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